The Shape of

Two-Step Injections

Maggie® is an easy-to-use, cartridge-based autoinjector built with SHL’s proprietary Needle Isolation Technology (NIT®). 

Join us at the 2020 PDA Universe of Pre-Filled Syringes and Injection Devices 

Join us at the 2020 PDA Universe

of  Pre-Filled Syringes and Injection Devices 

Oct 5-8

Virtual Event

Maggie®

Transform your cartridge-based treatment with Maggie®, a two-step autoinjector built with SHL’s proprietary Needle Isolation Technology (NIT®).

Needle Isolation Technology

Close

NIT® is a unique safety solution that makes it possible for cartridges to function like traditional pre-filled syringes with staked needles. Cartridges support higher volume dosing and enable dual-chamber treatments to be built as easy-to-use autoinjectors.

Higher Volume Injections

Close

Maggie® is built with a 3mL standard ISO cartridge to support the growing trend for high-volume dosing with the emergence of biologics and biosimilars. Cartridges also offer a level of needle customization for subcutaneous or intramuscular injections.

Automated Preparation

Close

Maggie®’s NIT® sub-assembly includes a pre-attached needle. Users simply untwist the cap to attach the needle and open the fluid path. The needle cover automatically extends and the autoinjector automatically primes.

Easy 2-Step Handling

Close

Injection with Maggie® is completed with just two simple steps: uncap and inject. The autoinjector needle cover locks out after injection, shielding patients from being exposed to te needle before and after injection.

Intuitive Feedback

Close

Maggie®’s large viewing window makes it easier for patients to inspect the drug before and during injection. It also features continuous audible clicks during injection, resulting in an easier determination of dose completion.

© 2020 SHL Medical AG. SHL, the SHL logo, and all other trademarks are property of SHL Medical AG and/or its affiliates.

Intuitive Feedback

Maggie®’s large viewing window makes it easier for patients to inspect the drug before and during injection. It also features continuous audible clicks during injection, resulting in an easier determination of dose completion.

Easy 2-Step Handling

Injection with Maggie® is completed with just two simple steps: uncap and inject. The autoinjector needle cover locks out after injection, shielding patients from being exposed to the needle before and after injection.

Automated Preparation

Maggie®’s NIT® sub-assembly includes a pre-attached needle. Users simply untwist the cap to attach the needle and open the fluid path. The needle cover automatically extends and the autoinjector automatically primes.

Higher Volume Injections

Maggie® is built with a 3mL standard ISO cartridge to support the growing trend for high-volume dosing with the emergence of biologics and biosimilars. Cartridges also offer a level of needle customization for subcutaneous or intramuscular injections.

Needle Isolation Technology

NIT® is a unique safety solution that makes it possible for cartridges to function like traditional pre-filled syringes with staked needles. Cartridges support higher volume dosing and enable dual-chamber treatments to be built as easy-to-use autoinjectors.

Go to article: Home | The logistics of delivering a global vaccineGo to article: In this issueGo to article: ContentsGo to article: MimotopesGo to article: SHL MedicalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: SwiftpakGo to article: CommentGo to article: Long HCC pipeline marks change for a previously stagnant marketGo to article: Pfizer and BioNTech’s Covid-19 vaccine candidate shows 90% efficacyGo to article: Blockchain-enabled hospital can provide real-world dataGo to article: The increasing influence of industry sponsors along the pandemic timelineGo to article: Digitalisation in pharmaceutical manufacturingGo to article: VEGA AustraliaGo to article: KugelmeiersGo to article: Unither PharmaceuticalsGo to article: In DepthGo to article: Special delivery: the logistics of curing Covid-19 Go to article: Will there ever be an HIV vaccine?Go to article: Predicting Covid-19 vaccine approvals with OpylGo to article: Unequal access: understanding cancer treatment disparity in EuropeGo to article: ‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?Go to article: Q&A: investing in innovative biotechs with Novo VenturesGo to article: Gold standard: why are Phase III trials so critical?Go to article: Brewprint: using yeast to make plant-based drugsGo to article: Air FranceGo to article: Zenatek Company Insight Go to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue